Chemical Compound

L-LYSINE, L-CYSTEINYL-L-LYSYL-L-GLUTAMINYL-D-CYSTEINYL-L-CYSTEINYL-3-AMINOALANYL-L-PHENYLALANYLGLYCYL-L-PROLYL-L-PHENYLALANYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-L-PHENYLALANYL-L-VALYL-L-CYSTEINYL-(3R)-3-HYDROXY-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-, CYCLIC-IMINE, CYCLIC (1->18),(4->14),(5->11)-TRIS(THIOETHER)

CAS Registry Number 1391-36-2
L-LYSINE, L-CYSTEINYL-L-LYSYL-L-GLUTAMINYL-D-CYSTEINYL-L-CYSTEINYL-3-AMINOALANYL-L-PHENYLALANYLGLYCYL-L-PROLYL-L-PHENYLALANYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-L-PHENYLALANYL-L-VALYL-L-CYSTEINYL-(3R)-3-HYDROXY-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-, CYCLIC-IMINE, CYCLIC (1->18),(4->14),(5->11)-TRIS(THIOETHER) 结构式
Primary record

L-LYSINE, L-CYSTEINYL-L-LYSYL-L-GLUTAMINYL-D-CYSTEINYL-L-CYSTEINYL-3-AMINOALANYL-L-PHENYLALANYLGLYCYL-L-PROLYL-L-PHENYLALANYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-L-PHENYLALANYL-L-VALYL-L-CYSTEINYL-(3R)-3-HYDROXY-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-, CYCLIC-IMINE, CYCLIC (1->18),(4->14),(5->11)-TRIS(THIOETHER)

库存
1,324 克
纯度
98.1 %
CAS
1391-36-2

化合物标识与属性

CAS
1391-36-2
PubChem CID
139593411
SMILES
C[C@H]1[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]3CSC[C@@H]4C(=O)N[C@@H](CS1)C(=O)N[C@@H](CNCCCC[C@H](NC(=O)[C@@H]([C@@H](SC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4)CCC(=O)N)CCCCN)N)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC3=O)[C@H](C(=O)O)O)CC(=O)N)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N[C@H](C(=O)N2)CC6=CC=CC=C6)CC7=CC=CC=C7)C(C)C)CC8=CC=CC=C8
Canonical SMILES
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CNCCCC[C@@H](C(=O)O)NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H]([C@@H](O)C(=O)O)NC(=O)[C@H](CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS[C@H]4C)C(=O)N[C@@H](CS[C@H]2C)C(=O)N3)NC1=O

名称与同义词

  • Duramycin
  • Leucopeptin
  • LANCOVUTIDE
  • lancovutida
  • lancovutidum
  • Lancovutide [INN]
  • Moli1901
  • Antibiotic PA 48009
  • BPR0F3X56H
  • Duramycin (~90%)
  • Lancovutide [WHO-DD]
  • Moli 1901
  • UNII-BPR0F3X56H
  • RefChem:152224
  • MOLI-1901
  • CHEBI:77834
  • BAT-012382
  • 1391-36-2
  • SID:96099904
  • CID:139593411
  • C477246
  • Ancovenin, 2-L-lysine-6-(3-aminoalanine)-10-L-phenylalanine-12-L-phenylalanine-13-L-valine-15-(erythro-3-hydroxy-L-aspartic acid)-, cyclic 6-19)-imine
  • (1S,4S,13S,16S,19S,22S,25S,28R,31S,37S,40S,44R,47S,50S,53S,56R,65S,70S)-44-amino-47-(4-aminobutyl)-37-(2-amino-2-oxoethyl)-50-(3-amino-3-oxopropyl)-4,16,22-tribenzyl-31-[(S)-carboxy(hydroxy)methyl]-70-methyl-2,5,8,14,17,20,23,26,29,32,35,38,45,48,51,54,57
  • 27,46-(Methaniminopentaniminomethano)-6,43:15,40-bis(methanothiomethano)pyrrolo[2,1-d1][1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52]thiaheptadecaazacyclopentapentacontine, cyclic peptide deriv.
  • 27,46-(Methaniminopentaniminomethano)-6,43:15,40-bis(methanothiomethano)pyrrolo[2,1-d1][1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52]thiaheptadecaazacyclopentapentacontine, cyclic peptide deriv.; Antibiotic PA 48009; Lancovutide; Leucopeptin; Moli 1901;
  • Ancovenin, 2-L-lysine-6-(3-aminoalanine)-10-L-phenylalanine-12-L-phenylalanine-13-L-valine-15-(erythro-3-hydroxy-L-aspartic acid)-, cyclic (6->19)-imine
  • L-LYSINE, L-CYSTEINYL-L-LYSYL-L-GLUTAMINYL-D-CYSTEINYL-L-CYSTEINYL-3-AMINOALANYL-L-PHENYLALANYLGLYCYL-L-PROLYL-L-PHENYLALANYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-L-PHENYLALANYL-L-VALYL-L-CYSTEINYL-(3R)-3-HYDROXY-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-(2S,3S)-2-AMINO-3-MERCAPTOBUTANOYL-, CYCLIC-IMINE, CYCLIC (1->18),(4->14),(5->11)-TRIS(THIOETHER)